- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02083302
Experimentally Testing the Effectiveness of a Campus-based Bystander Intervention
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 08901
- Rutgers, The State University of New Jersey
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Incoming first year students in the fall semester of 2010
- Age 18 - 21
- Attended Summer Orientation session
Exclusion Criteria:
- Incoming transfer students
- Younger than 18 or older than 21
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment1
The Treatment1 group received SCREAM Theater Dose 1, SCREAM Theater Dose 2 and SCREAM Theater Dose 3.
|
Intervention 1: A three part program: a skit acted out by peer educators that depicts a sexual assault; an in-character question and answer session; and an out-of-character information session.
Dose 2: Scenes from the skit from Session 1 are re-created with small groups of students, but stop at certain points to allow audience members to explore different bystander intervention possibilities. Dose 3: The six scenes outlined in Session 2 are presented individually to small groups of student participants; specifically outlining potential points of bystander intervention. |
|
Experimental: Treatment2
The Treatment2 group received SCREAM Theater Dose 1, SCREAM Theater Dose 2, SCREAM Theater Dose 3 and SCREAM Theater Dose 4.
|
Intervention 1: A three part program: a skit acted out by peer educators that depicts a sexual assault; an in-character question and answer session; and an out-of-character information session.
Dose 2: Scenes from the skit from Session 1 are re-created with small groups of students, but stop at certain points to allow audience members to explore different bystander intervention possibilities. Dose 3: The six scenes outlined in Session 2 are presented individually to small groups of student participants; specifically outlining potential points of bystander intervention.
Booster Session
|
|
Other: Control
The control group received SCREAM Theater Dose 1.
|
Intervention 1: A three part program: a skit acted out by peer educators that depicts a sexual assault; an in-character question and answer session; and an out-of-character information session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to three months
|
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information).
Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010.
All study participants received one dose of the intervention in June, July or August.
|
Change from baseline in bystander intentions to up to three months
|
|
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to six months
|
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information).
Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010.
After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
|
Change from baseline in bystander intentions to up to six months
|
|
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to eight months
|
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information).
Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
|
Change from baseline in bystander intentions to up to eight months
|
|
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to fifteen months
|
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information).
Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011.
After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
|
Change from baseline in bystander intentions to up to fifteen months
|
|
Bystander Intentions
Time Frame: Change from baseline in bystander intentions to up to twenty months
|
To measure intentions to be a bystander, we used the Bystander Attitude Scale, Revised (BAS-R) which is a modified version of Banyard's Bystander scale (Banyard, Plante, & Moynihan, 2005; see McMahon et al., in press, for scale development information).
Participants were asked to indicate how likely they were to engage in the behavior in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
|
Change from baseline in bystander intentions to up to twenty months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to three months
|
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R).
In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."Students'
bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010.
All study participants received one dose of the intervention in June, July or August.
|
Change from baseline in bystander friend norms to up to three months
|
|
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to six months
|
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R).
In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010.
After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
|
Change from baseline in bystander friend norms to up to six months
|
|
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to eight months
|
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R).
In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
|
Change from baseline in bystander friend norms to up to eight months
|
|
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to fifteen months
|
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R).
In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011.
After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
|
Change from baseline in bystander friend norms to up to fifteen months
|
|
Bystander Friend Norms
Time Frame: Change from baseline in bystander friend norms to up to twenty months
|
To measure friends' norms about being a bystander, we used the Bystander Attitude Scale, Revised (BAS-R).
In this portion of the survey, participants were asked to indicate how likely they think their friends would be to engage in the items on the BAS-R in the future on a Likert scale from 1 - 5, "Unlikely" to "Very likely."
Students' bystander friend norms were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
|
Change from baseline in bystander friend norms to up to twenty months
|
|
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to three months
|
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007).
Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do").
Students' bystander efficacy was assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010.
All study participants received one dose of the intervention in June, July or August.
|
Change from baseline in bystander efficacy to up to three months
|
|
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to six months
|
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007).
Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do").Students' bystander efficacy was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010.
After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
|
Change from baseline in bystander efficacy to up to six months
|
|
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to eight months
|
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007).
Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do").
Students' bystander efficacy was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
|
Change from baseline in bystander efficacy to up to eight months
|
|
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to fifteen months
|
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007).
Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do").
Students' bystander efficacy was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011.
After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
|
Change from baseline in bystander efficacy to up to fifteen months
|
|
Bystander Efficacy
Time Frame: Change from baseline in bystander efficacy to up to twenty months
|
To assess level of confidence in one's ability to intervene, the Bystander Efficacy Scale was used (Banyard et al., 2007).
Respondents were asked to rate their level of confidence that they would perform certain bystander behaviors on a scale of 0 ("can't do") to 100 ("very certain can do").
Students' bystander intentions were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
|
Change from baseline in bystander efficacy to up to twenty months
|
|
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to three months
|
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior.
For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month.
Respondents can indicate "Yes", "No", or "Wasn't in the Situation".Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010.
All study participants received one dose of the intervention in June, July or August.
|
Change from baseline in bystander behavior to up to three months
|
|
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to six months
|
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior.
For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month.
Respondents can indicate "Yes", "No", or "Wasn't in the Situation".Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010.
After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
|
Change from baseline in bystander behavior to up to six months
|
|
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to eight months
|
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior.
For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month.
Respondents can indicate "Yes", "No", or "Wasn't in the Situation".
Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
|
Change from baseline in bystander behavior to up to eight months
|
|
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to fifteen months
|
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior.
For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month.
Respondents can indicate "Yes", "No", or "Wasn't in the Situation".Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011.
After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
|
Change from baseline in bystander behavior to up to fifteen months
|
|
Bystander Behavior
Time Frame: Change from baseline in bystander behavior to up to twenty months
|
To measure actual bystander behavior, we used the Bystander Attitude Scale, Revised (BAS-R), which contains 18 items, each stating a different bystander behavior.
For this portion of the survey, participants were asked whether they actually participated in the behavior in the previous month.
Respondents can indicate "Yes", "No", or "Wasn't in the Situation".
Students' bystander behavior was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
|
Change from baseline in bystander behavior to up to twenty months
|
|
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to three months
|
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used.
The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011).
Students' rape myth acceptance was assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010.
All study participants received one dose of the intervention in June, July or August.
|
Change from baseline in rape myth acceptance to up to three months
|
|
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to six months
|
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used.
The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011).Students' rape myth acceptance was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010.
After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
|
Change from baseline in rape myth acceptance to up to six months
|
|
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to eight months
|
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used.
The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011).
Students' rape myth acceptance was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011.
|
Change from baseline in rape myth acceptance to up to eight months
|
|
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to fifteen months
|
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used.
The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011).Students' rape myth acceptance was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011.
After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
|
Change from baseline in rape myth acceptance to up to fifteen months
|
|
Rape Myth Acceptance
Time Frame: Change from baseline in rape myth acceptance to up to twenty months
|
A revised version of the Illinois Rape Myth Acceptance Scale (Payne, Lonsway, & Fitzgerald, 1999) was used.
The revised version (McMahon & Farmer, 2011) was selected because the scale includes updated language for college students as well as having a specific focus on accountability for rape and victim blaming (for information on scale development, see McMahon & Farmer, 2011).Students' rape myth acceptance assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
|
Change from baseline in rape myth acceptance to up to twenty months
|
|
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence to up to three months
|
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000).
These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010.
All study participants received one dose of the intervention in June, July or August.
|
Change from baseline in proclivity to perpetrate sexual violence to up to three months
|
|
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence to up to six months
|
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000).
These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010.
After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
|
Change from baseline in proclivity to perpetrate sexual violence to up to six months
|
|
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence to up to eight months
|
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000).
These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
|
Change from baseline in proclivity to perpetrate sexual violence to up to eight months
|
|
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence up to fifteen months
|
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000).
These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011.
After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
|
Change from baseline in proclivity to perpetrate sexual violence up to fifteen months
|
|
Proclivity to Perpetrate Sexual Violence
Time Frame: Change from baseline in proclivity to perpetrate sexual violence to up to twenty months
|
For proclivity to perpetrate, we used an item from Malamuth's (1989) Attraction to Sexual Aggression Scale and we created a question that combined items from Malamuth's scale and Lisak's Perpetrator History (PH) Scale (2000).
These measures were assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
|
Change from baseline in proclivity to perpetrate sexual violence to up to twenty months
|
|
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to three months
|
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration.
Students' past perpetration was assessed via (1) a paper survey in June, July or August 2010 (baseline) and (2) a follow-up web-based survey in early September, 2010.
All study participants received one dose of the intervention in June, July or August.
|
Change from baseline in sexual violence perpetration to up to three months
|
|
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to six months
|
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration.
Students' past perpetration was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; and (3) a follow-up web-based survey in early December 2010.
After the September, 2010 follow-up survey, participants were randomized to either receive two additional doses in October, 2010 and November, 2010 (experimental group) or no additional doses (control group).
|
Change from baseline in sexual violence perpetration to up to six months
|
|
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to eight months
|
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration.
Students' past perpetration was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; and (4) a follow-up web-based survey in February, 2011.
|
Change from baseline in sexual violence perpetration to up to eight months
|
|
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to fifteen months
|
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration.
Students' past perpetration was assessed via(1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; and (5) a follow-up web-based survey in September, 2011.
After the September, 2011 survey, experimental group participants were randomized to receive one additional dose (a booster session) or no additional doses.
|
Change from baseline in sexual violence perpetration to up to fifteen months
|
|
Sexual Violence Perpetration
Time Frame: Change from baseline in sexual violence perpetration to up to twenty months
|
Two questions from Lisak's Perpetrator History (PH) Scale (Lisak, Conklin, Hopper, Miller, Altschuler & Smith, 2000) were used to assess actual perpetration.
Students' past perpetration was assessed via (1) a paper survey in June, July or August 2010 (baseline); (2) a follow-up web-based survey in early September, 2010; (3) a follow-up web-based survey in early December 2010; (4) a follow-up web-based survey in February, 2011; (5) a follow-up web-based survey in September, 2011 and (6) a final follow-up web-based survey in February 2012.
|
Change from baseline in sexual violence perpetration to up to twenty months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Sarah McMahon, PhD, Rutgers University School of Social Work
- Principal Investigator: Judy Postmus, PhD, Rutgers University School of Social Work
Publications and helpful links
General Publications
- McMahon S, Allen CT, Postmus JL, McMahon SM, Peterson NA, Lowe Hoffman M. Measuring bystander attitudes and behavior to prevent sexual violence. J Am Coll Health. 2014;62(1):58-66. doi: 10.1080/07448481.2013.849258.
- McMahon, S., Hoffman, M., McMahon, S.M., Zucker, S. & Koenick, R.A. (2013). What Would You Do? Strategies for Bystander Intervention to Prevent Sexual Violence by College Students. Journal of College and Character, 14(2), p.141-152.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 07-412M
- 1R01CE001855-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Violence
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)CompletedViolence, Domestic | Violence | Violence, Sexual | Violence, Physical | Violence, Gender-Based | Violence-Related SymptomUnited States
-
University of PittsburghCenters for Disease Control and PreventionRecruitingViolence, Domestic | Violence in Adolescence | Violence, Sexual | Violence, Physical | Violence, Non-accidental | Social Cohesion | Violence, Structural | Community ViolenceUnited States
-
Medical Research Council, South AfricaUniversity of GhanaUnknownSexual Violence | Domestic Violence | Physical ViolenceGhana
-
Karolinska InstitutetRegion Stockholm; Jane and Dan Olsson Foundation for Scientific PurposesCompletedDomestic Violence | Family Violence | Intimate-partner ViolenceSweden
-
London School of Hygiene and Tropical MedicineInternational Rescue Committee; National Institutes of Medical Research, Tanzania and other collaboratorsUnknownChild Abuse | Violence | Violence, Physical | Violence Against Children
-
University of PittsburghCenters for Disease Control and PreventionCompletedViolence, Domestic | Coping Skills | Violence in Adolescence | Adolescent Behavior | Violence, Sexual | Violence, Physical | Violence, Non-accidental | Group, Peer | Emotional Abuse | Communication, PersonalUnited States
-
Johns Hopkins Bloomberg School of Public HealthUjamaa AfricaCompletedViolence, Domestic | Violence, Sexual | Violence, Gender-BasedKenya
-
University of PittsburghThe Grable Foundation; Department Human Services, Pennsylvania; Fisa FoundationCompletedViolence, Domestic | Coping Skills | Violence in Adolescence | Adolescent Behavior | Violence, Sexual | Violence, Physical | Violence, Non-accidental | Group, Peer | Emotional Abuse | Communication, PersonalUnited States
-
Johns Hopkins UniversityUniversity of Pittsburgh; Office of Research on Women's Health (ORWH); Futures...CompletedViolence, Domestic | Violence, SexualUnited States
-
University of PittsburghCompletedViolence in Adolescence | Domestic ViolenceUnited States
Clinical Trials on SCREAM Theater Dose 1
-
Medy-ToxCompletedLateral Canthal Lines | Glabellar LinesUnited States, Russian Federation, Germany, Canada, Belgium, United Kingdom
-
Zensun Sci. & Tech. Co., Ltd.Zensun USA Inc.CompletedChronic Heart FailureUnited States
-
Shanghai Fosun Pharmaceutical Industrial Development...Not yet recruiting
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707France
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Not yet recruitingSarcoma | Lymphoma | Kidney Cancer | Solid Tumors | MyelomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedUlcerative Colitis (UC)China
-
Virginia Commonwealth UniversityGilead SciencesWithdrawnChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | Refractory Small Lymphocytic Lymphoma | SLL | Relapsed CLL | Relapsed Chronic Lymphocytic Leukemia | Relapsed Small Lymphocytic Lymphoma
-
Oryn Therapeutics, LLCCompletedRheumatoid ArthritisUnited States
-
Loyola UniversityNational Cancer Institute (NCI)Active, not recruiting
-
Aronora, Inc.CompletedThrombosis | End Stage Renal DiseaseUnited States